Virus-like particles: a new family of delivery systems. Expert Rev. Vaccines 1:101-109.Boisgerault F, Moron G, Leclerc C. Virus-like particles: a new family of delivery systems. Expert Rev Vaccines 2002; 1:101-109.Boisgerault F,Moron G,Leclerc C.Virus-like particle:a new family of ...
Vaccines based on virus-like particle (VLP) technology aim at harnessing the potent immunogenicity of natural viruses devoid of any hazardous infectious trait. VLPs result from the self-assembling of single or multiple viral capsid proteins and have been shown to be safe and efficacious in humans....
Virus-like particles (VLPs) Virus-like particles are a class of delivery vehicles that resemble the structure of true virus particles, wherein the immune system rapidly recognizes them.131 VLPs address certain drawbacks of viral-based delivery systems: (i) the low likelihood of integration of vira...
Virus-Like Particle (VLP) Products and Services Playing a critical role in virology research www.creative-biolabs.com | Contact Us Virus-Like Particle (VLP) Virus Like Particle Native Virus Virus-like particles (VLPs) are nanostructures that resemble the structure of viruses. VLPs represent ...
Cuburu N, Chackerian B: Genital delivery of virus-like particle and pseudovirus-based vaccines. Expert Rev Vaccines 2011; 10:1245-1248.Cuburu N, Chackerian B (2011) Genital delivery of virus-like particle and pseudovirus-based vaccines. Expert Rev Vaccines 10: 1245-1248....
Therapeutic in vivo delivery of gene editing agents. Cell 185, 2806–2827 (2022). Article CAS PubMed PubMed Central Google Scholar Lyu, P., Wang, L. & Lu, B. Virus-like particle mediated CRISPR/Cas9 delivery for efficient and safe genome editing. Life https://doi.org/10.3390/life...
Chimeric papillomavirus (PV) virus-like particles (VLPs) based on the bovine papillomavirus type 1 (BPV-1) L1 protein were constructed by replacing the 23-carboxyl-terminal amino acids of the BPV1 major protein L1 with an artificial "polytope" minigene, containing known CTL epitopes of human PV...
Engineered virus-like particles (eVLPs) are promising vehicles for transient delivery of proteins and RNAs, including gene editing agents. We report a system for the laboratory evolution of eVLPs that enables the discovery of eVLP variants with improved
Virus-like particles (VLPs) comprise viral structural proteins that self-assemble to form a particle similar to the native virus capsid. Since their discovery, they have been employed mainly as vaccines to prevent viral infection because they can elicit an immune response. Besides their use as vac...
Virus-like particles (VLPs) are an effective means of establishing both prophylactic and therapeutic immunity against their source virus or heterologous antigens. The particulate nature and repetitive structure of VLPs makes them ideal for stimulating potent immune responses. Epitopes delivered by VLPs ca...